Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.000
-0.149 (-4.74%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $15.54 million as of March 30, 2026.
Market Cap
15.54M
Enterprise Value
10.13M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $15.54M, a decrease of -60.60%. That is a compound annual growth rate of -95.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 16.31M | -53.28% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MDA Space | 3.43B |
| Versamet Royalties | 1.00B |
| Blue Moon Metals | 545.35M |
| FreeCast | 162.61M |
| JM Group | 134.27M |
| CTW Cayman | 133.50M |
| Meridian Holdings | 91.86M |
| Filana Therapeutics | 80.67M |